Credit: Huy Mach/Washington University
Randall J. Bateman, MD, of Washington University School of Medicine in St. Louis, led an international trial evaluating whether investigational drugs could slow memory loss and cognitive decline in a rare, inherited form of Alzheimer's disease. The trial was conducted at 24 sites in Australia, Canada, France, Spain, the United Kingdom and the United States.